Daehan Nupharm Co.,Ltd.

KOSDAQ:A054670 Stock Report

Market Cap: ₩80.8b

Daehan NupharmLtd Dividends and Buybacks

Dividend criteria checks 1/6

Daehan NupharmLtd is a dividend paying company with a current yield of 1.74%.

Key information

1.7%

Dividend yield

n/a

Buyback Yield

Total Shareholder Yieldn/a
Future Dividend Yieldn/a
Dividend Growthn/a
Next dividend pay daten/a
Ex dividend daten/a
Dividend per sharen/a
Payout ration/a

Recent dividend and buyback updates

Recent updates

Analysis Article • Nov 20

Solid Earnings May Not Tell The Whole Story For Daehan NupharmLtd (KOSDAQ:054670)

Daehan Nupharm Co.,Ltd.'s ( KOSDAQ:054670 ) healthy profit numbers didn't contain any surprises for investors. We...
Analysis Article • Mar 10

Daehan New Pharm Co., Ltd.'s (KOSDAQ:054670) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock?

Daehan New Pharm (KOSDAQ:054670) has had a rough three months with its share price down 17%. However, a closer look at...
Analysis Article • Feb 17

What Type Of Shareholders Own The Most Number of Daehan New Pharm Co., Ltd. (KOSDAQ:054670) Shares?

If you want to know who really controls Daehan New Pharm Co., Ltd. ( KOSDAQ:054670 ), then you'll have to look at the...
Analysis Article • Jan 21

Here's Why Daehan New Pharm (KOSDAQ:054670) Can Manage Its Debt Responsibly

Some say volatility, rather than debt, is the best way to think about risk as an investor, but Warren Buffett famously...
Analysis Article • Dec 31

If You Had Bought Daehan New Pharm's (KOSDAQ:054670) Shares Five Years Ago You Would Be Down 25%

Ideally, your overall portfolio should beat the market average. But the main game is to find enough winners to more...
Analysis Article • Dec 10

Is Daehan New Pharm Co., Ltd.'s(KOSDAQ:054670) Recent Stock Performance Tethered To Its Strong Fundamentals?

Daehan New Pharm's (KOSDAQ:054670) stock is up by a considerable 7.1% over the past month. Given the company's...

Stability and Growth of Payments

Fetching dividends data

Stable Dividend: Too early to tell whether A054670's dividend payments have been stable as they only just started paying a dividend.

Growing Dividend: Too early to tell if A054670's dividend payments are increasing as they only just started paying a dividend.

Dividend Yield vs Market

Daehan NupharmLtd Dividend Yield vs Market
How does A054670 dividend yield compare to the market?
SegmentDividend Yield
Company (A054670)1.7%
Market Bottom 25% (KR)1.4%
Market Top 25% (KR)4.3%
Industry Average (Pharmaceuticals)1.0%
Analyst forecast (A054670) (up to 3 years)n/a

Notable Dividend: A054670's dividend (1.74%) is higher than the bottom 25% of dividend payers in the KR market (1.39%).

High Dividend: A054670's dividend (1.74%) is low compared to the top 25% of dividend payers in the KR market (4.34%).

Earnings Payout to Shareholders

Earnings Coverage: Insufficient data to calculate A054670's payout ratio to determine if its dividend payments are covered by earnings.

Cash Payout to Shareholders

Cash Flow Coverage: A054670 is paying a dividend but the company has no free cash flows.

Discover strong dividend paying companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2026/08/07 13:26
End of Day Share Price 2026/08/07 00:00
Earnings2026/03/31
Annual Earnings2025/12/31

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* Example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.

Analyst Sources

Daehan Nupharm Co.,Ltd. is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.